[1] 马丽媛, 吴亚哲, 王文, 等. 《中国心血管病报告2017》要点解读[J]. 中国心血管杂志, 2018, 23(1):3-6. [2] Turcani M, Fizel A, Maasova D, et al. The pathophysiology of heart failure[J]. Bratisl Lek Listy, 1988, 89(3):211-219. [3] Verschure D O, Van Eck-Smit B L, Somsen G A, et al. Cardiac sympathetic activity in chronic heart failure:cardiac123I-mIBG scintigraphy to improve patient selection for ICD implantation[J]. Neth Heart J, 2016, 24(12):701-708. [4] Andersen S, Andersen A, De Man F S, et al. Sympathetic nervous system activation and beta-adrenoceptor blockade in right heart failure[J]. Eur J Heart Fail, 2015, 17(4):358-366. [5] Holthoff H P, Zeibig S, Jahns-Boivin V, et al. Detection of anti-beta1-AR autoantibodies in heart failure by a cell-based competition ELISA[J]. Circ Res, 2012, 111(6):675-684. [6] Becker N P, Goettel P, Mueller J, et al. Functional autoantibody diseases:basics and treatment related to cardiomyopathies[J]. Front Biosci (Landmark Ed), 2019, 24:48-95. [7] Bovo E, Mazurek S R, De Tombe P P, et al. Increased energy demand during adrenergic receptor stimulation contributes to Ca2+ wave generation[J]. Biophys J, 2015, 109(8):1583-1591. [8] Wang L, Li Y, Ning N, et al. Decreased autophagy induced by beta1-adrenoceptor autoantibodies contributes to cardiomyocyte apoptosis[J]. Cell Death Dis, 2018, 9(3):406. [9] Liu H R, Zhao R R, Zhi J M, et al. Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages[J]. Autoimmunity, 1999, 29(1):43-51. [10] 杜芸辉, 李笑, 于海存,等. 一种新型β1肾上腺素受体单克隆抗体的制备及其临床应用[J]. 心肺血管病杂志, 2017, 36(8):696-700. [11] Lohse M J, Engelhardt S, Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure?[J]. Circ Res, 2003, 93(10):896-906. [12] He J Q, Balijepalli R C, Haworth R A, et al. Crosstalk of beta-adrenergic receptor subtypes through Gi blunts beta-adrenergic stimulation of L-type Ca2+ channels in canine heart failure[J]. Circ Res, 2005, 97(6):566-573. [13] Reina S, Ganzinelli S, Sterin-Borda L, et al. Pro-apoptotic effect of anti-beta1-adrenergic receptor antibodies in periodontitis patients[J]. Int Immunopharmacol, 2012, 14(4):710-721. [14] Jahns R, Boivin V, Siegmund C, et al. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure[J]. Circulation, 1999, 99(5):649-654. [15] Jahns R, Boivin V, Krapf T, et al. Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies[J]. J Am Coll Cardiol, 2000, 36(4):1280-1287. [16] Wallukat G, Morwinski M, Kowal K, et al. Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy:beta-adrenergic agonism without desensitization[J]. Eur Heart J, 1991, 12(Suppl D):178-181. [17] Liang C S, Mao W, Liu J. Pro-apoptotic effects of anti-beta1-adrenergic receptor antibodies in cultured rat cardiomyocytes:actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway[J]. Autoimmunity, 2008, 41(6):434-441. [18] Teerlink J R, Pfeffer J M, Pfeffer M A. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats[J]. Circ Res, 1994, 75(1):105-113. [19] Banoth B, Cassel S L. Mitochondria in innate immune signaling[J]. Transl Res, 2018,202:52-68. [20] Berezhnaya E, Neginskaya M, Uzdensky A B, et al. Photo-induced oxidative stress impairs mitochondrial metabolism in neurons and astrocytes[J]. Mol Neurobiol, 2018, 55(1):90-95. [21] Ferreira G, Costa C, Bassaizteguy V, et al. Incubation of human sperm with micelles made from glycerophospholipid mixtures increases sperm motility and resistance to oxidative stress[J]. PLoS One, 2018, 13(6):e0197897. [22] Agnihotri S K, Agrawal A K, Hakim B A, et al. Mitochondrial membrane potential (MMP) regulates sperm motility[J]. In Vitro Cell Dev Biol Anim, 2016, 52(9):953-960. |